Last week's market action certainly opened up the possibility that this decline will turn into a bear market, as all the market pundits who were so bullish just a couple of months ago now can't wait to go to the dark side. There are many questions to be answered: Will we slide into recession? Will government actions help? Will the bond insurers go belly up? Of course, when these questions are answered, there will inevitably be more to take their place. I'm still relying on my indicators to point me in the right investment direction. Those long-term indicators are not giving me much help right now, though, because they remain neutral:
Overall, this confluence of indicators leads me to reduce my target cash position to 10% from 15%. At the end of last week, my IRA was holding a cash position of 13.1%, so I will be doing some buying this week. SalesLast week, I eliminated a couple of holdings from my IRA. I sold the remainder of my position in EnerSys (ENS) because the stock seems overvalued by at least 10% at current price levels. I also sold my position in Parexel (PRXL) because I had held that stock for seven months and it no longer appears on my screening system as a buy. In order to hold my cash position near the previous 15% target, I bought some SPDR Trust (SPY) .PurchasesI took a new position last week in U.S. Physical Therapy (USPH) . This company takes partnership and profit-sharing stakes in businesses that provide physical and occupational therapy to clients. Improving demographics should help this company grow, as an older population increasingly requires help with pre- and postoperative care for orthopedic surgery. Past growth has been good, but not as good as industry averages. However, the company now seems more interested in growing the business and has started to make some acquisitions. The company has a solid financial position with a debt-to-equity ratio of 0.21 and a current ratio of 3.3. Return on equity and assets are substantially above industry norms. Valuation, though, is well below industry averages when looking at price over sales, price over book or price over cash flow. The company's enterprise value/EBITDA ratio is about a 25% discount to the median company in the specialized medical services industry. The following table shows all of the current holdings in my IRA. I'm not too disappointed in my performance so far this year, because I have been able to stay pretty close to the S&P 500. This is a tough and volatile market, but I'm going to maintain an unemotional approach; I expect a better environment over the next couple of months.
Please note that due to factors including low market capitalization and/or insufficient public float, we consider Axsys Technology, Exactech, ICF International, Elizabeth Arden, L.S. Starrett, U.S. Physical Therapy, Columbus McKinnon and GP Strategies to be small-cap stocks. You should be aware that such stocks are subject to more risk than stocks of larger companies, including greater volatility, lower liquidity and less publicly available information, and that postings such as this one can have an effect on their stock prices. RELATED STORIES More Problems for VM The Gaming Industry Is No Roll of the Dice IRA Investing: The Volatility Continues IRA Investing: Long-Term Indicators at a Crossroads Revisiting the Recession Playbook IRA Investing: A Bit More Optimistic
At the time of publication, Moore was long Axsys Technologies,
Cal-Maine Foods,
CommScope,
Exactech,
Frontier Oil,
CGI Group,
Helmerich & Payne,
ICF International,
Kinetic Concepts,
Open Text,
Elizabeth Arden,
Rofin-Sinar Technologies,
L.S. Starrett,
Stone Energy,
SPDR Trust,
Sybase,
URS Corp.,
U.S. Physical Therapy and
Western Digital,
although positions may change at any time.
Richard Moore, CFA, has 40 years of experience in various facets of the investment business. He has been employed by banks, mutual funds and investment advisory organizations during his career and has also owned retail and service businesses. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Moore appreciates your feedback; click here to send him an email.
Read our conflicts and disclosure policy. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Terms of Use | Privacy Policy
© 1996- TheStreet.com, Inc. All rights reserved. |